JD Health International, Inc. (HK:6618)
:6618
Want to see HK:6618 full AI Analyst Report?
Total Valuation
JD Health International, Inc. has a market cap or net worth of HK$130.29B. The enterprise value is HK$81.87B.
Market CapHK$130.29B
Enterprise ValueHK$81.87B
Share Statistics
JD Health International, Inc. has 3,210,775,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,210,775,100
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
JD Health International, Inc.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.53%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)5.53%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee20.61M
Profits Per Employee1.47M
Employee Count3,564
Asset Turnover0.90
Inventory Turnover8.05
Valuation Ratios
The current PE Ratio of JD Health International, Inc. is 14.3. JD Health International, Inc.’s PEG ratio is 1.03.
PE Ratio14.3
PS Ratio2.17
PB Ratio2.65
Price to Fair Value2.65
Price to FCF0.00
Price to Operating Cash Flow10.90
PEG Ratio1.03
Income Statement
In the last 12 months, JD Health International, Inc. had revenue of 73.44B and earned 5.38B in profits. Earnings per share was 1.70.
Revenue73.44B
Gross Profit18.20B
Operating Income3.80B
Pretax Income6.03B
Net Income5.38B
EBITDA3.98B
Earnings Per Share (EPS)1.70
Cash Flow
In the last 12 months, operating cash flow was 10.31B and capital expenditures -4.10B, giving a free cash flow of 6.21B billion.
Operating Cash Flow10.31B
Free Cash Flow6.21B
Free Cash Flow per Share1.93
Dividends & Yields
JD Health International, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.40
52-Week Price Change-0.78%
50-Day Moving Average47.43
200-Day Moving Average57.93
Relative Strength Index (RSI)34.07
Average Volume (3m)7.60M
Important Dates
JD Health International, Inc. upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
JD Health International, Inc. as a current ratio of 2.72, with Debt / Equity ratio of 1.06%
Current Ratio2.72
Quick Ratio2.39
Debt to Market Cap0.00
Net Debt to EBITDA-7.84
Interest Coverage Ratio342.22
Taxes
In the past 12 months, JD Health International, Inc. has paid 662.89M in taxes.
Income Tax662.89M
Effective Tax Rate0.11
Enterprise Valuation
JD Health International, Inc. EV to EBITDA ratio is 32.28, with an EV/FCF ratio of 0.00.
EV to Sales1.75
EV to EBITDA32.28
EV to Free Cash Flow0.00
EV to Operating Cash Flow12.92
Balance Sheet
JD Health International, Inc. has HK$47.00B in cash and marketable securities with HK$636.29M in debt, giving a net cash position of HK$46.36B billion.
Cash & Marketable SecuritiesHK$47.00B
Total DebtHK$636.29M
Net CashHK$46.36B
Net Cash Per ShareHK$14.44
Tangible Book Value Per ShareHK$18.18
Margins
Gross margin is 24.78%, with operating margin of 5.17%, and net profit margin of 7.32%.
Gross Margin24.78%
Operating Margin5.17%
Pretax Margin8.21%
Net Profit Margin7.32%
EBITDA Margin5.41%
EBIT Margin5.17%
Analyst Forecast
The average price target for JD Health International, Inc. is HK$71.58, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$71.58
Price Target Upside18.70% Upside
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast26.35%
EPS Growth Forecast28.38%